Informações:
Falhas:
ID
39891
Descrição
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.; ODM derived from: https://clinicaltrials.gov/show/NCT01258439
Link
https://clinicaltrials.gov/show/NCT01258439
Palavras-chave
Versões (1)
- 29/02/2020 29/02/2020 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
29 de fevereiro de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility HIV NCT01258439
Eligibility HIV NCT01258439
- StudyEvent: Eligibility
Similar models
Eligibility HIV NCT01258439
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Informed Consent
Item
provision of signed, informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age >18 years
boolean
C0001779 (UMLS CUI [1])
HIV Infections | HIV Antibody Measurement | Western blot for HIV
Item
hiv infection documented by hiv antibody test and western blot prior to study entry
boolean
C0019693 (UMLS CUI [1])
C3714540 (UMLS CUI [2])
C0860963 (UMLS CUI [3])
C3714540 (UMLS CUI [2])
C0860963 (UMLS CUI [3])
Antiretroviral therapy Absent
Item
no previous art or no art for 6 months prior to randomisation
boolean
C1963724 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
CD4+ Count | Viral load measurement
Item
cd4+ count of <500 cells/mm or viral load >10,000 copies/ml within 60 days prior to randomisation
boolean
C0243009 (UMLS CUI [1])
C1261478 (UMLS CUI [2])
C1261478 (UMLS CUI [2])
Absence Resistance Genotypic Raltegravir | Absence Resistance Genotypic Tenofovir | Absence Resistance Genotypic Emtricitabine | Absence Resistance Genotypic Darunavir | Absence Resistance Genotypic Ritonavir
Item
no genotypic resistance to raltegravir, tenofovir/emtricitabine, darunavir, ritonavir
boolean
C0332197 (UMLS CUI [1,1])
C1514892 (UMLS CUI [1,2])
C0017431 (UMLS CUI [1,3])
C1871526 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
C0017431 (UMLS CUI [2,3])
C0384228 (UMLS CUI [2,4])
C0332197 (UMLS CUI [3,1])
C1514892 (UMLS CUI [3,2])
C0017431 (UMLS CUI [3,3])
C0909839 (UMLS CUI [3,4])
C0332197 (UMLS CUI [4,1])
C1514892 (UMLS CUI [4,2])
C0017431 (UMLS CUI [4,3])
C1435444 (UMLS CUI [4,4])
C0332197 (UMLS CUI [5,1])
C1514892 (UMLS CUI [5,2])
C0017431 (UMLS CUI [5,3])
C0292818 (UMLS CUI [5,4])
C1514892 (UMLS CUI [1,2])
C0017431 (UMLS CUI [1,3])
C1871526 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
C0017431 (UMLS CUI [2,3])
C0384228 (UMLS CUI [2,4])
C0332197 (UMLS CUI [3,1])
C1514892 (UMLS CUI [3,2])
C0017431 (UMLS CUI [3,3])
C0909839 (UMLS CUI [3,4])
C0332197 (UMLS CUI [4,1])
C1514892 (UMLS CUI [4,2])
C0017431 (UMLS CUI [4,3])
C1435444 (UMLS CUI [4,4])
C0332197 (UMLS CUI [5,1])
C1514892 (UMLS CUI [5,2])
C0017431 (UMLS CUI [5,3])
C0292818 (UMLS CUI [5,4])
Body mass index
Item
body mass index less than 30kg/m2
boolean
C1305855 (UMLS CUI [1])
Primary HIV infection Recent
Item
primary hiv infection within the last 6 months
boolean
C1142553 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
Communicable Disease Recent | Opportunistic Infection Recent
Item
active infection or opportunistic illness within the previous 30 days
boolean
C0009450 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0029118 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0332185 (UMLS CUI [1,2])
C0029118 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Pharmaceutical Preparation Contraindicated Darunavir+Ritonavir | Pharmaceutical Preparation Contraindicated Raltegravir
Item
use of any medication contra-indicated with ritonavir-boosted darunavir or raltegravir
boolean
C0013227 (UMLS CUI [1,1])
C1444657 (UMLS CUI [1,2])
C1976853 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C1871526 (UMLS CUI [2,3])
C1444657 (UMLS CUI [1,2])
C1976853 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C1871526 (UMLS CUI [2,3])
Lipid-lowering therapy
Item
use of lipid-lowering therapy
boolean
C0585943 (UMLS CUI [1])
Diabetes Mellitus | Glucose measurement, fasting
Item
diabetes mellitus (fasting glucose >7.0mml/l or a prior diagnosis of diabetes)
boolean
C0011849 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
C0202045 (UMLS CUI [2])
Oral prednisolone U/day | Equivalent
Item
use of oral prednisolone > 7.5mg daily or equivalent
boolean
C0358513 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0205163 (UMLS CUI [2])
C0456683 (UMLS CUI [1,2])
C0205163 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Hypersensitivity Component Study Meal
Item
proven hypersensitivity to one or more components of the study meal
boolean
C0020517 (UMLS CUI [1,1])
C1705248 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1998602 (UMLS CUI [1,4])
C1705248 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1998602 (UMLS CUI [1,4])